Found 100 matching trials
Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation PHASE4 To compare in a randomized prospective study the effectiveness and toxicity...
Show More Location
University of Miami Division of Transplantation
Learn More & Join Trial
Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis PHASE2 The primary objective of this study is to determine whether DAC HYP, when c...
Show More Learn More & Join Trial
Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation. PHASE3 To compare the efficacy and safety of two regimens containing tacrolimus an...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Daclizumab in Patients With Chronic, Persistent Asthma PHASE2 The purpose of the study is to evaluate an investigational medication to tr...
Show More Location
Medical Research Associates
Learn More & Join Trial
Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA) PHASE4 The main aim of this study is to compare the renal function (serum creatini...
Show More Location
Hospital Universitario Marqués de Valdecilla
Learn More & Join Trial
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer PHASE2 RATIONALE: Monoclonal antibodies such as daclizumab can locate tumor cells ...
Show More Location
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
Learn More & Join Trial
Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD PHASE4 The purpose of this study is to see whether serious graft versus host disea...
Show More Location
University of Iowa Hospitals
Learn More & Join Trial
Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 PHASE3 The primary objective of the study is to assess the safety and tolerability...
Show More Learn More & Join Trial
HAT in Eye Complications of Behcet's Disease PHASE2 This study will evaluate the safety and effectiveness of Zenapax in control...
Show More Location
National Eye Institute (NEI)
Learn More & Join Trial
LMB-2 to Treat Hairy Cell Leukemia PHASE2 Background:
* About 80% of patients with hairy cell leukemia (HCL) have tu...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial